In vitro haemocompatibility of a novel bioprosthetic total artificial heart

European Journal of Cardio-Thoracic Surgery, 05/21/2012

Haemocompatibility of the TAH blood–contacting surfaces was confirmed by in vitro studies showing a limited consumption of fibrin, limited thromboxane B2 release and platelet adhesion, and minor blood cell depositions on the surfaces. These results will be validated in clinical studies, with the aim of reducing anti–coagulation when using the CARMAT TAH.

Print Article Summary Cat 2 CME Report